Production (Stage)
HCW Biologics Inc.
HCWB
$5.49
-$0.09-1.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.11M | 4.67M | 998.20K | 1.16M | 4.08M |
| Total Receivables | 87.50K | 582.20K | 651.80K | 655.00K | 903.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 256.30K | 328.20K | 356.20K | 404.90K | 783.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 443.30K | 113.50K | 88.10K | 164.60K | 437.30K |
| Total Current Assets | 1.89M | 5.70M | 2.09M | 2.39M | 6.21M |
|
|
|||||
| Total Current Assets | 1.89M | 5.70M | 2.09M | 2.39M | 6.21M |
| Net Property, Plant & Equipment | 22.76M | 22.91M | 22.83M | 22.81M | 22.59M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 28.50K | 28.50K | 28.50K | 28.50K | 28.50K |
| Total Assets | 26.29M | 30.24M | 26.56M | 26.82M | 30.43M |
|
|
|||||
| Total Accounts Payable | 19.73M | 22.33M | 22.67M | 16.88M | 10.49M |
| Total Accrued Expenses | 1.17M | 981.90K | 930.70K | 6.22M | 2.92M |
| Short-term Debt | 6.23M | 6.31M | 6.34M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 126.00K | 124.00K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.14M | 29.63M | 30.06M | 23.22M | 13.41M |
|
|
|||||
| Total Current Liabilities | 27.14M | 29.63M | 30.06M | 23.22M | 13.41M |
| Long-Term Debt | 7.71M | 7.38M | 6.46M | 9.90M | 8.27M |
| Short-term Debt | 6.23M | 6.31M | 6.34M | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.85M | 37.01M | 36.53M | 33.12M | 21.69M |
|
|
|||||
| Common Stock & APIC | 94.19M | 93.79M | 87.21M | 86.98M | 86.74M |
| Retained Earnings | -102.75M | -100.56M | -97.18M | -93.28M | -78.00M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.56M | -6.77M | -9.97M | -6.30M | 8.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.56M | -6.77M | -9.97M | -6.30M | 8.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.56M | -6.77M | -9.97M | -6.30M | 8.74M |
|
|
|||||